ABSTRACT: Objective: Mothers of advanced maternal age (AMA) at childbirth (age ‡35 years) may have different perceptions of autism spectrum disorder (ASD) risk, independent of sociodemographic factors, that may affect ASD identification. We aimed to estimate associations between AMA and both age of a child's first evaluation noting developmental concerns and time from first evaluation to first ASD diagnosis. Methods: We used data for 8-year-olds identified with ASD in the 2008 to 2012 Autism and Developmental Disabilities Monitoring Network. We estimated differences in age at first evaluation noting developmental concerns and time to first ASD diagnosis by AMA using quantile and Cox regression. Results: Of 10,358 children with ASD, 19.7% had mothers of AMA. AMA was associated with higher educational attainment and previous live births compared with younger mothers. In unadjusted analyses, AMA was associated with earlier first evaluation noting developmental concerns (median 37 vs 40 mo) and patterns in time to first evaluation (hazard ratio: 1.12, 95% confidence interval: 1.06-1.18). Associations between AMA and evaluation timing diminished and were no longer significant after adjustment for socioeconomic and demographic characteristics. Children's intellectual disability did not modify associations between AMA and timing of evaluations. Conclusion: Advanced maternal age is a sociodemographic factor associated with younger age of first evaluation noting developmental concerns in children with ASD, but AMA was not independently associated likely, because it is a consequence or cofactor of maternal education and other sociodemographic characteristics. AMA may be a demographic factor to consider when aiming to screen and evaluate children at risk for ASD.
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Advanced maternal age (AMA), or childbirth at or after the age of 35 years, is a risk factor for an array of poor pregnancy and children's health outcomes. AMA increases the risk of stillbirth, fetal loss, preterm birth, preeclampsia, and gestational diabetes. 1 Children of AMA mothers are at a greater risk of being small for gestational age, having low birth weight, 1 Down syndrome, 2 and congenital malformations. 3 AMA is also associated with children's intellectual disability (ID) 4 and autism spectrum disorder (ASD). 5 A meta-analysis by Sandin et al. 5 of 25,687 ASD cases and 8,655,576 controls pooled from 16 epidemiological studies found an adjusted and statistically significant relative risk for ASD of 1.31 comparing mothers aged $35 years with mothers aged 25 to 29 years. Etiologic hypotheses for this increased risk include genomic alterations, environmental exposures, and epigenetic mechanisms. 5 Many mothers of AMA are aware of their higher risk for nonoptimal pregnancy outcomes compared with younger mothers. 6 This awareness may be related to the increased levels of education and higher socioeconomic status (SES) associated with pregnancy at older age. 7 Independent of these SES and demographic factors, the increased risk for poorer pregnancy outcomes at older age is often explicitly communicated to all mothers of AMA. Best obstetrician practice recommends both additional screenings for fetal aneuploidy and clear communication with mothers of AMA about their increased risk. 8 Understanding patterns in the awareness of these enhanced risks is important because increased awareness affects how a woman seeks care and adopts certain health behaviors. 8 Studies have found that a portion of parents of children with ASD attribute their child's ASD to maternal age 9, 10 ; however, research has not assessed whether the increased risk of ASD among children with AMA mothers affects screening and evaluation of ASD. Reducing age at ASD evaluation and identification is important because early identification and intervention provide short-and longterm benefits to the child and family. 11 Previous studies have evaluated maternal or paternal age as a predictor of early age at ASD diagnosis. Some studies have found an association between older maternal age and younger age at child diagnosis, 12, 13 whereas others have found no such association.
14,15 These studies may not capture the lag from first evaluation to diagnosis, which can be an extended period. 16 In addition, these studies address maternal age as an additional covariate in models that aim to evaluate another exposure or group of exposures; this approach does not appropriately account for confounding or capture the independent effects of maternal age.
Identifying children with ASD at an early age is associated with improved developmental outcomes and reduced health expenditures. 17 Although early screening for ASD is not mandatory in the United States, 18 universal early screening and evaluation may help identify those at greatest risk and reduce diagnostic disparities. 15, 19 Understanding how children with ASD get evaluated and diagnosed may help us understand which factors to target when aiming to reduce age at identification. AMA is 1 such factor to assess because it is both a risk factor for ASD and a demographic characteristic that may affect service usage.
Our objective was to estimate effects of AMA on age when children with ASD had their first evaluation that noted developmental concerns and time from that evaluation to first ASD diagnosis among a group of children with ASD identified from the Autism and Developmental Disabilities Monitoring Network. We hypothesized that after controlling for confounding effects such as maternal education and live birth order, we would still see AMA to be associated with younger child age at first evaluation noting developmental concerns, which is likely through increased knowledge about the risk due to AMA. In addition, we explored whether ID in the child modified associations because co-occurring ID may be associated with maternal age.
METHODS

Autism and Developmental Disability Monitoring Network
The Autism and Developmental Disabilities Monitoring Network (ADDM) is a multisite, population-based surveillance program funded by the Centers for Disease Control and Prevention with the goal of estimating the prevalence of autism spectrum disorder (ASD) in 8-and 4-year-old children in the United States using a standardized methodology. 20 Data have been collected biennially since 2000. All participating study sites received institutional review board approval.
Autism and Developmental Disabilities Monitoring Network Case Ascertainment
Eligible children had their records reviewed in ADDM if their age was 8 years and had at least 1 parent who resided in the site's defined geographic area during the surveillance year. Trained abstractors screened a child's special education records and/or health records from community providers that serve children with developmental disabilities for ADDM-specified behavioral and diagnostic triggers. Behavioral triggers include impairment in social gestures and expressions, joint attention problems, lack of a social use of language, and social delay before age 3 years. Diagnostic triggers include a past diagnosis of ASD, a special education eligibility of autism, or an autism test. If at least 1 trigger was present, a study clinician reviewed all of a child's developmental evaluations in special education and health records and used a highly structured standardized scoring protocol based on the DSM-IV-Text Revision (DSM-IV-TR) to deduce ASD case status. This protocol examined whether there is sufficient information on the record to conclude that the child meets DSM-IV-TR criteria for autistic disorder, Asperger syndrome, or pervasive developmental disability not otherwise specified; a previous diagnosis for 1 of these conditions was not necessary to receive case confirmation in ADDM. DSM-IV-TR criteria were used because data collection preceded implementation of DSM5. Initial interrater reliability was set at a minimum of 90% agreement on final case status, and 80% to 90% agreement for individual variables. 20 Further information about ADDM methods and scoring protocols has been provided by Rice et al. 20 and Christensen et al. 21 
Study Population
For this secondary analysis of ADDM data, we included all 8-year-old children with ASD identified in surveillance years 2008, 2010, and 2012 from 13 ADDM sites that participated in any of the 3 surveillance years (Alabama, Arkansas, Arizona, Colorado, Georgia, Maryland, Missouri, North Carolina, New Jersey, Pennsylvania, South Carolina, Utah, and Wisconsin) (n 5 14,416). We restricted analysis to these surveillance years to minimize differences in ASD prevalence and geographic surveillance area over time. These surveillance years correspond to birth years of 2000, 2002, and 2004 . In addition, we excluded children without linked birth certificates, whom we did not have maternal age information on (N 5 4058).
Outcome Variable
We defined the child's earliest evaluation noting developmental concern as the first evaluation conducted by a trained professional who noted an ADDM behavioral or developmental trigger or a DSM-IV-TR-defined associated feature of ASD. 22 Associated features included aggression, self-injurious behaviors, hyperactivity, and odd response to sensory stimuli and were abstracted by ADDM and indicate developmental issues. Evaluations were conducted most frequently by occupational therapists, speech-language pathologists, psychologists, and developmental pediatricians. In 165 cases, children underwent a developmental evaluation before the age of 8 months. Many of these traits may not emerge until the latter parts of the first and second year 23 ; therefore, we excluded these observations because measuring ASD and other developmental traits at this age is often unreliable. 17 In addition, no evaluation before 8 months in our data indicated what specific measurement tool was used, preventing us from assessing validity of the data. To evaluate this assumption, we conducted sensitivity analyses that included evaluations before 8 months.
Autism and Developmental Disabilities Monitoring Network clinicians determined first ASD diagnosis as the earliest date on the child's record of an ASD diagnosis given by a qualified professional. In certain instances, the date at first evaluation noting developmental concerns was also the date of ASD diagnosis. To determine time from first evaluation that noted ASD traits to first diagnosis, we subtracted age at first diagnosis in months from age at first evaluation in months.
Advanced Maternal Age
Maternal age at childbirth was derived from the child's birth certificate. Advanced maternal age (AMA) was defined as age at childbirth $35 years based on the standard convention. There were no implausible values and minimal missing data for this variable (N 5 7).
Intellectual Disability
As a secondary objective, we examined whether effects of AMA differed based on whether the child had intellectual disability (ID). Children's ID status was abstracted during the record review process based on whether there was an indication of an intellectual quotient (IQ) test in the record. Not all children in our sample had data on ID status largely because of differences in whether health records, education records, or both were collected at an individual site. We elected to restrict this subanalysis to children from sites that had collected data on ID in .60% of children (Alabama, Arkansas, Arizona, Colorado, Georgia, Maryland, North Carolina, New Jersey, South Carolina, and Utah). ADDM defined ID as an IQ test with a score #70 or a statement from an examiner indicating ID. 24 We present results from this analysis in 3 strata: ID, no ID, and missing ID status.
Covariates
We used demographic variables from the child's birth certificate to describe sample characteristics and control for confounding. To account for missing paternal age data, we used the multiple-imputation procedure in SAS 9.4 using a fully conditional specification method. We assumed that these data were missing at random, conditional on known covariates; therefore, we included all other covariates and children's age at first evaluation that noted ASD traits in our imputation model. Twenty-five data sets were imputed and pooled for our adjusted analyses. Imputation was redone for the subanalysis that restricted analyses to sites that collected adequate ID data. As a sensitivity analysis, we restricted to just those with paternal age data and found that point estimates changed by less than 5% (data not shown); therefore, we elected to present results using the imputed data to maximize precision.
Data Analysis
Chi-square tests were conducted comparing AMA and categorical demographic covariates to assess the correlation between AMA and confounders. Student's t test were used for normally distributed continuous variables and the Wilcoxon's signed-rank test for non-normally distributed continuous variables. We then ran unadjusted and adjusted models to assess differences in age at first evaluation in 2 ways. Because outcome measures were not normally distributed, we used quantile regression to estimate median age differences at the deciles for first evaluation and time to diagnosis (because 39% of those with a formal diagnosis had a first diagnosis at the time of first evaluation, we present only the fourth to ninth deciles). Second, we examined differences in a time-toevent framework using Cox proportional hazard models. This allowed us to assess whether the patterns in time to evaluation differed by AMA. Children without ASD diagnoses on their record but with ASD as determined by ADDM methodology were considered administratively censored. These children had not had a formal diagnosis by the end of data collection (age 8 years), so they were right censored. An advantage to this approach is that we are able to incorporate these observations into our semiparametric methods, although they do not have a time of diagnosis; however, if there were missing data on the time of diagnosis, it may be incorrectly censored. We used the imputed data sets and included covariates identified as confounders a priori: maternal education, maternal race/ethnicity, paternal age, parity, birth order, gestational age, child's year of birth, and study site. In addition, we reran these analyses with our outcome being the difference from the first evaluation to first ASD diagnosis. All analyses were conducted using SAS 9.4 (SAS Institute Inc, Cary, NC).
RESULTS
Of 10,358 children that met our entry criteria, 2432 were identified in surveillance year 2008, 4066 in 2010, and 3860 in 2012 (Table 1) . Overall, 2036 mothers (19.7%) were of advanced maternal age (AMA) at the time of childbirth. A larger percentage of AMA mothers were white and had a college degree compared with non-AMA mothers. AMA mothers were also more likely to have had more previous live births, have the child be on of a multiple birth, and have an older father of the child than non-AMA mothers. Children of AMA mothers had a mean age of first evaluation noting developmental concern of 42.2 months (median 5 37 months) and a mean time from first evaluation to first diagnosis of 11.52 months (median 5 3 months). Of these children, Age at first evaluation noting developmental concern (mean months, SD)
,0.0001 reported in their records. Children of non-AMA mothers had a mean age of 44.65 months (median 5 40 months) at their first evaluation noting developmental concern, and it took an average of 11.70 months (median 5 3 months) from the first evaluation to the first diagnosis. Of these children, 26.3% met ADDM ASD criteria but did not have an ASD diagnosis on their record. The imputed paternal age variable was associated with and strongly correlated with AMA (p , 0.0001; Pearson's correlation 5 0.73).
In the unadjusted model (Fig. 1) , there was a difference in age at first evaluation noting developmental concern by AMA, with the median time for children of AMA mothers being identified between 1 and 5 months earlier than in non-AMA mothers (depending on decile). These differences were statistically significant in all but the first decile. After adjustment for socioeconomic and demographic confounders, differences in medians ranged from 0.6 months later to 1.4 months earlier, and only the 20th and 30th percentile groups met statistical significance. When the child had a formal diagnosis of ASD on their record, the median time from first evaluation noting developmental concern to ASD diagnosis did not differ in deciles by AMA in most unadjusted and all adjusted analyses (Fig. 2) . Similar results (data not shown) were found in our sensitivity analysis that included children with first evaluation age that noted ASD traits ,8 months.
When assessing these differences using Cox proportional hazard models (Table 2) , the patterns in age at first evaluation noting developmental concern significantly differed in the unadjusted model (hazard ratio [HR]: 1.12, 95% confidence interval [CI]: 1.06-1.18) but not in the adjusted model (HR: 1.02, 95% CI, 0.96-1.08). When assessing time from first evaluation to first ASD diagnosis, we found an unadjusted HR of 1.08 (95% CI, 1.02-1.14), which was no longer significant after adjustment (HR: 1.03, 95% CI: 0.96-1.10); this indicates that the distributions over time did not differ by AMA status.
Finally, we stratified our analysis by intellectual disability (ID) status. After subsetting our sample to sites that collected ID status for .60% of children, 8412 children were included in this subanalysis: 2332 (27.7%) had ID, 4608 (54.8%) did not, and 1472 (17.5%) were missing ID data. Children with ID had a first evaluation noting developmental concern earlier compared with children without ID (mean/median age with ID: 37.9/35 months and mean/median age without ID: 47.5/44 months), and in unadjusted analyses, there were significant earlier evaluations noting first concerns by AMA in both groups with and without ID. However, there were no significant differences by AMA in any ID group in any decile after adjustment (Table 3) . Furthermore, there were no associations between AMA and time between first evaluation noting developmental concern and first diagnosis of ASD in any ID group. As an additional post hoc analysis, we examined effect modification by stratifying on maternal education or child's birth order; no strata found significant associations between AMA and age at first evaluation that noted ASD traits.
DISCUSSION
In an analysis of 3 years of prevalence data for 8-year-old children with autism spectrum disorder (ASD) across the United States, we found that all observed associations between advanced maternal age (AMA) and age at which a child with ASD first had an evaluation noting developmental concern were largely explained by other sociodemographic factors, namely maternal education. In addition, we did not observe significant associations after adjusting for other maternal characteristics when evaluating time from first evaluation noting developmental concern to first diagnosis of ASD, including after stratification by child intellectual disability (ID).
We hypothesized that age at first evaluation noting developmental concern would be independently associated with AMA because of a potential increased perception of risk due to being of AMA. Ultimately, this was Figure 1 . Differences in median age at first evaluation noting developmental concern in children with autism spectrum disorder at the deciles and corresponding 95% confidence intervals comparing children of mothers of advanced maternal age with those with mothers not of advanced maternal age, identified by the Autism and Developmental Disabilities Monitoring Network in 2008, 2010, and 2012. Advanced maternal age (AMA) is defined as childbirth at $35 years of age. Difference is age at first evaluation noting developmental concern for children of AMA mothers-non-AMA mothers. Adjusted model controlled for maternal race/ethnicity, maternal education, study site, child's year of birth, child's gestational age, paternal age, parity, birth order, and record type with multiple imputations to account for missing paternal age data.
not the case because significant differences in medians at the deciles and hazard ratios (HRs) were attenuated to the null after adjustment for socioeconomic status and demographic factors. A key factor in the association between timing of developmental evaluations or ASD diagnoses is race and ethnicity. Age at first ASD diagnosis is associated with race in population-based studies and black children are sometimes found to be diagnosed later than white children. 13, 25 The race/ethnicity disparity in age at diagnosis may be attributable to diagnostic bias 26 or access to care. 27 In our data, we found that AMA mothers were significantly more likely to be white, which supports race/ethnicity as a factor that could have led to increased crude estimates. Whether attributable to AMA or race, we find clear evidence of disparity, with children of younger, non-white mothers getting evaluated later.
Similarly, education is highly associated with disparity and access to care. Pettygrove et al. 28 found that children in the 2002 Autism and Developmental Disabilities Monitoring Network (ADDM) surveillance year who were missing health records (likely because of a lack of access to health care) were from census blocks with lower levels of parental education, fewer parents with a college degree, and had children with later first diagnoses of ASD. Again, our data illustrate disparity by a factor associated with AMA because younger mothers who are more likely to have lower education levels had their children with ASD identified later.
Birth order may also have confounded the unadjusted associations that we observed. A mother with previous children may be more acutely aware of atypical development compared with a first-time mother because concerns about a child's development arise sooner when there is an older child for comparison. 29 Furthermore, ASD is highly heritable, 30 and it is likely that some children with ASD identified in ADDM have an older sibling with ASD. In this case, mothers tend to have earlier developmental concerns for the later child. 29 These familial dynamics need to be further explored and accounted for to better understand ways to reduce age at ASD diagnosis.
In addition, we examined time from first evaluation noting developmental concern to first diagnosis of ASD by AMA. Approximately one-fifth of children who met the standardized criteria for ASD in our data did not have a record indicating that they had formally received an ASD diagnosis, but the existence of an ASD diagnosis was not differential by AMA. In a previous ADDM study, Wiggins et al. 16 found a 13-month delay between first evaluation and first diagnosis, and the delay was associated with cognitive impairment. We had hypothesized that mothers of AMA would have more experience and knowledge of the health system Figure 2 . Differences in median time from first evaluation noting developmental concern to first autism diagnosis by decile and 95% confidence intervals by advanced maternal age in children with a past autism diagnosis identified by the Autism and Developmental Disabilities Monitoring Network in 2008, 2010, and 2012. Advanced maternal age (AMA) is defined as childbirth at $35 years of age. Difference is the number of months for time from first evaluation noting developmental concern to first autism diagnosis in children of AMA mothers compared with children with non-AMA mothers. Adjusted model controlled for maternal race/ethnicity, maternal education, study site, child's year of birth, child's gestational age, paternal age, parity, birth order, and record type with multiple imputations to account for missing paternal age data. Deciles 10 to 30 are not shown because the time difference was 0 for all observations. that could enable earlier diagnosis. Similarly to age at first evaluation, we saw significant unadjusted associations when evaluating HRs, but results were attenuated to the null after adjustment. Again, the crude association was likely attributable to the confounding socioeconomic and demographic factors that affect access to care. In agreement with the literature, 14, 16 we found that children with ASD and ID had first evaluations noting developmental concern earlier than children with ASD without ID. AMA may be associated with ASD phenotype (including co-occurring ID), 31 and by stratifying by the child's ID status, we were able to explore effects of co-occurring ID on evaluation and diagnostic timing. For both age at first evaluation and time from first evaluation to first diagnosis, there were significant crude differences but no significant differences by AMA status for any ID strata after adjustment. In our data, the percent of AMA mothers among children with and without ID was similar (19.3% of mothers of children with ID and 20.4% of mothers of children without ID), which may not support ID as a mediating factor. More refined phenotypic measurement, like ASD severity, in children with ASD may be needed to identify the connection between AMA, children's presentation, and evaluation and diagnosis. Our study was limited by having only data on children with ASD, which prevented us from assessing the effect of AMA on ASD screening and evaluation in the general population. We lacked data to fully evaluate what led to the initial ASD evaluation and any reason for a specific delay such as a lack of access. We were not able to characterize the level of the mother's concern, identify and account for children who were not raised by the mother indicated on the birth certificate, and account for the influence of the father's concern. Although we used multiple-imputation methods to reduce the impact of missing paternal age, the effectiveness of this technique relies on the assumption that data were missing at random, conditional on covariates, and that the imputation model is correctly specified. We adjusted for appropriate confounders, but some residual confounding may have remained, especially at the level of community-specific factors. Using semiparametric Cox models, we assumed that those observations that were censored truly did not have a diagnosis of ASD by 8 years and were not missing data on a diagnosis. Based on the thorough ADDM methodology, we are confident in this assumption. We were able to use ID status as a representation of the child's phenotype because it was a co-occurring condition that was consistent over time. Missing ID status could have impacted our findings; however, we restricted our analyses to sites that had the least amount of missing ID data and presented our findings for those with missing ID data from those sites.
The strengths of this study include the use of data from ADDM, which enabled us to use a large sample of children with ASD identified from across the United States using a standardized surveillance methodology. We assessed 2 different outcomes (age at first evaluation and time from first evaluation to first diagnosis) to better understand how AMA affects the diagnostic process. In addition, we modeled these associations in 2 semiparametric ways: calculating differences in median at the deciles and calculating HRs using models appropriately adjusted for confounding. Incorporating the Cox models and a time-to-event framework allowed us to use data on one-fifth of our sample that did not have a formal diagnosis of ASD by 8 years old. By stratifying our results among a subset with ID data, we explored the effect of a common co-occurring condition of ASD that may be associated with AMA and age at first evaluation.
These findings highlight the high correlation between AMA and other sociodemographic factors in the timing of a child's ASD evaluations. Children with ASD and older mothers were more likely to have earlier evaluations noting developmental concerns, and this can be attributed to higher socioeconomic status and racial and ethnic disparity in ASD identification. AMA, being a risk factor for ASD, does not independently contribute to earlier age at children's evaluation and diagnosis. Understanding how risk factors for ASD impact evaluation patterns will help to reduce age at diagnosis in those at highest risk.
